Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MBX Biosciences (MBX) Change in Account Payables (2023 - 2026)

MBX Biosciences has reported Change in Account Payables over the past 4 years, most recently at $4.0 million for Q1 2026.

  • Quarterly results put Change in Account Payables at $4.0 million for Q1 2026, up 353.96% from a year ago — trailing twelve months through Mar 2026 was $3.1 million (up 63.05% YoY), and the annual figure for FY2025 was -$2.5 million, down 162.54%.
  • Change in Account Payables reached $4.0 million in Q1 2026 per MBX's latest filing, up from -$861000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $4.0 million in Q1 2026 and bottomed at -$2.0 million in Q3 2025.
  • Median Change in Account Payables over the past 4 years was $526500.0 (2024), compared with a mean of $513300.0.
  • The largest annual shift saw Change in Account Payables tumbled 429.96% in 2025 before it surged 353.96% in 2026.
  • Over 4 years, Change in Account Payables stood at -$310000.0 in 2023, then skyrocketed by 308.06% to $645000.0 in 2024, then plummeted by 233.49% to -$861000.0 in 2025, then skyrocketed by 561.32% to $4.0 million in 2026.
  • Business Quant data shows Change in Account Payables for MBX at $4.0 million in Q1 2026, -$861000.0 in Q4 2025, and -$2.0 million in Q3 2025.